Significant Cardiac Rhythm Disturbances in Infant Bronchiolitis: A Holter-Based Prospective Analysis.
J Pediatr Clin Pract 2026 Jun; 20:200209.

Abstract

OBJECTIVE

Bronchiolitis is a major cause of respiratory illness in infants. Few studies have demonstrated arrhythmias during bronchiolitis, including bradycardia and atrioventricular block, some requiring pacemaker implantation. However, the association between bronchiolitis and cardiac arrhythmias remains unclear. In this work we sought to investigate the incidence and characteristics of arrhythmias during bronchiolitis in infants younger than 1 year of age.

STUDY DESIGN

A single-center, prospective cohort study was conducted on infants hospitalized with a clinical diagnosis of bronchiolitis. Demographic and clinical data were collected via questionnaire. All infants underwent overnight Holter monitoring during hospitalization.

RESULTS

Among 100 enrolled infants (79% positive for respiratory syncytial virus), 18 (18%) demonstrated arrhythmias: sinus arrest (2-13 seconds) in 8 infants, bradycardia <60 bpm in 7 infants, and frequent atrial premature complexes (3%-18% of beats) in 3 infants. Follow-up Holter recordings in 7 patients (38%) showed resolution of arrhythmias within 1-4 months. No significant demographic or clinical predictors were identified. None of the infants exhibited symptoms (eg, cyanosis, unresponsiveness) associated with arrhythmia severity.

CONCLUSIONS

Our study shows that bronchiolitis is associated with significant arrhythmias in infants, particularly sinus arrest, bradycardia, and atrial premature complexes. In our cohort, none of the infants with significant arrhythmia required arrhythmia intervention. Clinicians should be aware of this association and consider delaying decisions regarding pacemaker implantation until after the resolution of bronchiolitis even in cases of infants with severe bradycardia. Future investigations should explore the pathophysiology and prognostic implications of this phenomenon.

Authors+Show Affiliations

Raphael ADepartment of Pediatrics, The Eisenberg R&D Authority, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel.
Asad HDepartment of Pediatrics, The Eisenberg R&D Authority, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel.
Rav-Acha MFaculty of Medicine, Cardiology Department, Sha'are Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Tovia-Brodie OFaculty of Medicine, Cardiology Department, Sha'are Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Michowitz YFaculty of Medicine, Cardiology Department, Sha'are Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Dadon ZFaculty of Medicine, Cardiology Department, Sha'are Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Schlesinger YDepartment of Pediatrics, The Eisenberg R&D Authority, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel. Pediatric Infectious Diseases Unit, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel.
Nir ADepartment of Pediatrics, The Eisenberg R&D Authority, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel. Pediatric Cardiology and Adult Congenital Heart Disease Unit, Wilf Children Hospital, Sha'are Zedek Medical Center, Affiliated to the Hadassah-Hebrew University Medical School, Jerusalem, Israel.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

42027860